Validation of Prognostic Scoring Systems for Patients With mRCC Enrolled in Phase I Clinical Trials
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Validation of Prognostic Scoring Systems for Patients With Metastatic Renal Cell Carcinoma Enrolled in Phase I Clinical Trials
ESMO Open 2020 Nov 01;5(6)e001073, AW Hahn, O Alhalabi, P Msaouel, F Meric-Bernstam, A Naing, E Jonasch, S Piha-Paul, D Hong, S Pant, T Yap, E Campbell, H Le, NM Tannir, J Roszik, V SubbiahFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.